PHF13: A Potential Drug Target Or Biomarker for Ovarian Cancer

Target Name: PHF13

NCBI ID: G148479

PHF13

PHF13: A Potential Drug Target Or Biomarker for Ovarian Cancer

PHF13 is a protein that is expressed in high levels in ovarian cancer cells. It is also associated with the survival of these cells. Researchers have been interested in studying PHF13 because they believe that it may be a drug target or biomarker for ovarian cancer. In this article, we will explore the science behind PHF13 and its potential as a drug target or biomarker.

PHF13 is a protein that is derived from the phosphatidylinositol (PIP) system. This system is a structure that is found in all cell types and is involved in the production of signaling molecules called phospholipids. PHF13 is a 21-kDa protein that is expressed in high levels in ovarian cancer cells. It is found in the cytoplasm and the endoplasmic reticulum.

One of the things that makes PHF13 so interesting is its association with the survival of ovarian cancer cells. Studies have shown that PHF13 is a powerful predictor of the survival of ovarian cancer cells. This means that the higher the level of PHF13 is in a cancer cell, the longer the cell is likely to live.

This association between PHF13 and the survival of ovarian cancer cells makes it an attractive drug target or biomarker. Researchers are trying to find ways to block the activity of PHF13 in order to kill or slow down the growth of ovarian cancer cells. This could lead to the development of a new treatment for ovarian cancer.

Another potential way to use PHF13 as a drug target or biomarker is to use it as a diagnostic tool. Researchers have shown that the levels of PHF13 are elevated in ovarian cancer cells, which could be used as a indicator of the presence of this cancer. This could make PHF13 an useful diagnostic tool for ovarian cancer, particularly in cases where the disease has not been diagnosed.

PHF13 is also an interesting biomarker for ovarian cancer because it is expressed in high levels in all ovarian cancer cell types, including epithelial and stromal tumors. This makes it a useful tool for studying the different types of ovarian cancer, and for identifying new biomarkers for these cancers.

In conclusion, PHF13 is a protein that is associated with the survival of ovarian cancer cells. As a result, it is an attractive drug target or biomarker for these diseases. Further research is needed to fully understand the role of PHF13 in ovarian cancer and to identify its potential as a new treatment or diagnostic tool.

Protein Name: PHD Finger Protein 13

Functions: Modulates chromatin structure. Required for normal chromosome condensation during the early stages of mitosis. Required for normal chromosome separation during mitosis

The "PHF13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHF13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets